Skip to main content

Table 2 NKG2D-expressing NK and T cells

From: Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions

  Percentage of NKG2D-expressing cells
Subjects CD56 + CD3 - CD56 - CD3 +
  Mean
± SD
Min Max p Mean
± SD
Min Max p
Healthy 50.40 ±
20.78
21.44 83.84   24.80 ±
7.67
17.30 40.20  
LSIL 28.57 ±
1.36
3.60 78.40 0.010 15.74 ±
6.91
6.40 28.50 0.041
HSIL 40.90 ±
5.67
2.70 88.10 0.495 12.20 ±
7.49
2.40 22.80 0.011
Invasive carcinoma 27.49 ±
9.62
0.50 82.90 0.034 8.28 ±
0.25
0.10 29.60 0.005
  1. p represents the value obtained of comparing LSIL, HSIL, and carcinoma subjects vs healthy subjects